1. Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
- Author
-
Dubrava,Alex L, Kyaw,Pan Su Pyae, Newman,Joseph, Pringle,Jarrad, Westhuyzen,Justin, La Hera Fuentes,Gina, Shakespeare,Thomas P, Sakalkale,Renukadas, Aherne,Noel J, Dubrava,Alex L, Kyaw,Pan Su Pyae, Newman,Joseph, Pringle,Jarrad, Westhuyzen,Justin, La Hera Fuentes,Gina, Shakespeare,Thomas P, Sakalkale,Renukadas, and Aherne,Noel J
- Abstract
Alex L Dubrava,1,2 Pan Su Pyae Kyaw,1,2 Joseph Newman,1,2 Jarrad Pringle,1,2 Justin Westhuyzen,3 Gina La Hera Fuentes,2 Thomas P Shakespeare,1,2 Renukadas Sakalkale,2,4 Noel J Aherne1â 3 1Department of Radiation Oncology, Mid North Coast Cancer Centre, Coffs Harbour, New South Wales, Australia; 2Coffs Harbour Rural Clinical School, University of New South Wales, Coffs Harbour Health Campus, Coffs Harbour, New South Wales, Australia; 3School of Health and Human Sciences, Southern Cross University, Coffs Harbour, New South Wales, Australia; 4Coffs Harbour Base Hospital Pathology, Coffs Harbour, New South Wales, AustraliaCorrespondence: Noel J Aherne, Department of Radiation Oncology, Mid North Coast Cancer Centre, Coffs Harbour Hospital, Coffs Harbour, New South Wales, 2450, Australia, Tel + 61 2 6656 5125, Fax +61 2 6656 5855, Email noel.aherne@health.nsw.gov.auPurpose: Triple negative breast cancer (TNBC) is a breast carcinoma subtype that neither expresses estrogen (ER) and progesterone receptors (PR) nor the human epidermal growth factor receptor 2 (HER2). Patients with TNBC have been shown to have poorer outcomes mainly owing to the limited treatment options available. However, some studies have shown TNBC tumors expressing androgen receptors (AR), raising hopes of its prognostic role.Patients and Methods: This retrospective study investigated the expression of AR in TNBC and its relationship with known patient demographics, tumor and survival characteristics. From the records of 205 TNBC patients, 36 had available archived tissue samples eligible for AR staining. For statistical purposes, tumors were classified as either âpositiveâ or ânegativeâ for AR expression. The nuclear expression of AR was scored by measuring the percentage of stained tumor cells and its staining intensity.Results: AR was expressed by 50% of the tissue samples in our TNBC cohort. The relationship between AR status with age at the time of TNBC diagnosis was statistically signific
- Published
- 2023